A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T Cells
Top Cited Papers
- 31 July 2008
- journal article
- Published by Elsevier BV in Gastroenterology
- Vol. 135 (1), 234-243
- https://doi.org/10.1053/j.gastro.2008.03.020
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Immune surveillance of tumorsJCI Insight, 2007
- All-trans-Retinoic Acid Improves Differentiation of Myeloid Cells and Immune Response in Cancer PatientsCancer Research, 2006
- Myeloid suppressor cells in cancer: Recruitment, phenotype, properties, and mechanisms of immune suppressionSeminars in Cancer Biology, 2006
- Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinomaWorld Journal of Gastroenterology, 2006
- Arginase-Producing Myeloid Suppressor Cells in Renal Cell Carcinoma Patients: A Mechanism of Tumor EvasionCancer Research, 2005
- Increased Populations of Regulatory T Cells in Peripheral Blood of Patients with Hepatocellular CarcinomaCancer Research, 2005
- Reduction of Myeloid-Derived Suppressor Cells and Induction of M1 Macrophages Facilitate the Rejection of Established Metastatic DiseaseThe Journal of Immunology, 2005
- Spontaneous Tumor-Specific Humoral and Cellular Immune Responses to NY-ESO-1 in Hepatocellular CarcinomaClinical Cancer Research, 2004
- Peptide–β2-microglobulin–MHC fusion molecules bind antigen-specific T cells and can be used for multivalent MHC–Ig complexesJournal of Immunological Methods, 2002
- Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in CancerThe Journal of Immunology, 2001